A detailed history of Boothbay Fund Management, LLC transactions in Biomerica Inc stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 51,894 shares of BMRA stock, worth $22,833. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,894
Holding current value
$22,833
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.82 - $1.29 $42,553 - $66,943
51,894 New
51,894 $43,000
Q3 2023

Nov 14, 2023

SELL
$0.82 - $1.65 $49,218 - $99,036
-60,022 Reduced 20.39%
234,357 $201,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.87 $41,389 - $69,105
36,955 Added 14.36%
294,379 $400,000
Q1 2023

May 15, 2023

BUY
$1.86 - $3.56 $478,808 - $916,429
257,424 New
257,424 $481,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $5.91M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.